Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
N/A
0 New
0 $0
Q2 2024

Jul 23, 2024

BUY
N/A
0 New
0 $0
Q1 2024

Apr 30, 2024

BUY
N/A
0 New
0 $0
Q4 2023

Feb 07, 2024

BUY
N/A
0 New
0 $0
Q3 2023

Oct 30, 2023

BUY
N/A
0 New
0 $0
Q3 2023

Oct 25, 2023

BUY
N/A
0 New
0 $0
Q2 2023

Aug 10, 2023

BUY
N/A
0 New
0 $0
Q1 2023

May 15, 2023

BUY
$3.46 - $4.07 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023

BUY
$3.07 - $7.21 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022

BUY
$5.6 - $7.03 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022

BUY
$4.59 - $7.99 $0 - $0
0 New
0 $0

Others Institutions Holding AIKI

About AIkido Pharma Inc.


  • Ticker AIKI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,485,100
  • Market Cap $20.8M
  • Description
  • AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...
More about AIKI
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.